The Ensign Group, Inc. (ENSG) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $197.92. It has a SharesGrow Score of 58/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ENSG = $157.17 (-20.6% from the current price, the stock appears overvalued). Analyst consensus target is ENSG = $222 (+12.3% upside).
Valuation: ENSG trades at a trailing Price-to-Earnings (P/E) of 33.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.53.
Financials: revenue is $5.1B, +18.7%/yr average growth. Net income is $344M, growing at +17%/yr. Net profit margin is 6.8% (thin). Gross margin is 13.7% (-3.4 pp trend).
Balance sheet: total debt is $4.2B against $2.2B equity (Debt-to-Equity (D/E) ratio 1.86, leveraged). Current ratio is 1.42 (adequate). Debt-to-assets is 76.1%. Total assets: $5.5B.
Analyst outlook: 9 / 13 analysts rate ENSG as buy (69%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 29/100 (Fail), Growth 80/100 (Pass), Past 100/100 (Pass), Health 50/100 (Partial), Moat 43/100 (Fail), Future 61/100 (Pass), Income 45/100 (Partial).
